Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Oxford Health Clinical Research Facility (OH CRF) is one of 28 facilities across England to benefit from nearly £161 million that has been awarded by the National Institute for Health Research (NIHR) to expand early phase clinical research delivery in NHS hospitals.

Doctor analysing a futuristic hologram of the human brain.

Professor Andrea Cipriani, Director of the Oxford Health NHS FT CRF said: 

 

'We are delighted to have been awarded this prestigious funding by the NIHR for another five years. The funding will enable us to continue to deliver innovative early phase clinical research. It is crucial to have dedicated space and staff for mental health research. We will work in close collaboration with the University of Oxford, Oxford Brookes University and other NHS Trusts, as well as with our many industry partners to test and develop better treatments for patients.'

This is the only dedicated mental health CRF supported by the NIHR. During the pandemic the CRF adapted to support the delivery of two major vaccine trials.

 

Dr Nick Broughton, CEO Oxford Health NHS Foundation Trust said:

 

'It is a great credit to the achievements of the Oxford Health CRF to receive this significant new funding from the NIHR. Research is a key strategic priority for Oxford Health and we're proud to host the CRF and to support its delivery of early translational and experimental medicine research.'

Read more on the NIHR Oxford Health Biomedical Research Centre website.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

New Study Shows Simvastatin Can Change the Way People Experience Certain Emotions

This new study examines the effects of simvastatin on emotional processing, reward learning, verbal memory, and inflammation.

Oxford has Largest Volume of World-Leading Research - REF 2021

Results of the Research Excellence Framework (REF) 2021 for UK universities indicate that Oxford has the largest volume of world-leading research*.

Cathy Creswell Elected Fellow of Academy of Medical Sciences

Cathy Creswell, Professor of Developmental Clinical Psychology, Departments of Psychiatry and Experimental Psychology, University of Oxford, has been elected a Fellow of the Academy of Medical Sciences.

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.

Anxiety Disorders Among Children, Assessment and Working with Families

Anxiety disorders are the most common mental health disorders among children, yet there is limited guidance on the process of assessing child anxiety disorders and sharing diagnostic outcomes with families.

Landmark New Clinical Trial Shows Benefits of Automated Virtual Reality (VR) Treatment for Severe Psychological Problems

The gameChange automated VR program is designed to treat agoraphobia in patients with psychosis. In the largest ever clinical trial of virtual reality for mental health, gameChange especially helped people whose anxiety had previously left them virtually housebound.